Table 2. Predictive concordance of FDZS, TNM and BCLC based on A09 or non-A09.
FDZS5 | FDZS3 | TNM | A09+TNM | BCLC | A09+BCLC | ||
Concordance | Concordance | Concordance | Concordance | Concordance | Concordance | ||
Training | Combined | 0.667 | 0.672 | 0.602 | 0.617 | ||
Separated | 0.72 | 0.687 | 0.679 | 0.683 | 0.671 | 0.678 | |
Internal validation | Combined | 0.624 | 0.63 | 0.62 | 0.629 | ||
Separated | 0.63 | 0.608 | 0.641 | 0.649 | 0.653 | 0.664 | |
External validation | Combined | 0.788 | 0.85 | 0.688 | 0.85 | ||
Separated | 0.85 | 0.762 | 0.862 | 0.95 | 0.75 | 0.888 |
Calculated with tumor number, size, MVI, LN in TNM staging system and tumor number, size, MVI, TB, Child-Pugh in BCLC staging system(separated) or TNM, BCLC(combined).